Kybella (Deoxycholic Acid) Drug Interactions: 89 Moderate
Kybella (Deoxycholic Acid) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kybella. Always confirm against the full prescribing information.
100 interactions
Acetylsalicylic acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Deoxycholic acid.
Level 1 evidence
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Aluminum chloride
Aluminum chloride can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Aluminum chlorohydrate
Aluminum chlorohydrate can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Aluminum sulfate
Aluminum sulfate can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Anagrelide
The risk or severity of adverse effects can be increased when Anagrelide is combined with Deoxycholic acid.
Level 1 evidence
Atazanavir
Deoxycholic acid may increase the excretion rate of Atazanavir which could result in a lower serum level and potentially a reduction in efficacy.
Level 2 evidence
Atenolol
Deoxycholic acid may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy.
Level 2 evidence
Atorvastatin
Deoxycholic acid may increase the excretion rate of Atorvastatin which could result in a lower serum level and potentially a reduction in efficacy.
Level 2 evidence
Atropine
Deoxycholic acid may increase the excretion rate of Atropine which could result in a lower serum level and potentially a reduction in efficacy.
Level 2 evidence
Belantamab mafodotin
Deoxycholic acid may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.
Kybella (Deoxycholic Acid) has 132 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Kybella (Deoxycholic Acid) has 0 major, 89 moderate, and 43 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kybella. Always confirm against the full prescribing information.